158 related articles for article (PubMed ID: 16470551)
21. Buschke-Ollendorff syndrome: a manifestation of a heterozygous nonsense mutation in the LEMD3 gene.
Gass JK; Hellemans J; Mortier G; Griffiths M; Burrows NP
J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S103-4. PubMed ID: 18489034
[No Abstract] [Full Text] [Related]
22. Buschke-Ollendorff syndrome associated with hypertrophic scar formation: a possible role for LEMD3 mutation.
Korekawa A; Nakano H; Toyomaki Y; Takiyoshi N; Rokunohe D; Akasaka E; Nakajima K; Sawamura D
Br J Dermatol; 2012 Apr; 166(4):900-3. PubMed ID: 21985280
[No Abstract] [Full Text] [Related]
23. Melorheostosis in a family with autosomal dominant osteopoikilosis.
Nevin NC; Thomas PS; Davis RI; Cowie GH
Am J Med Genet; 1999 Feb; 82(5):409-14. PubMed ID: 10069713
[TBL] [Abstract][Full Text] [Related]
24. Melorheostosis in a patient with familial osteopoikilosis.
Butkus CE; Michels VV; Lindor NM; Cooney WP
Am J Med Genet; 1997 Oct; 72(1):43-6. PubMed ID: 9295073
[TBL] [Abstract][Full Text] [Related]
25. Mutation in LEMD3 (Man1) Associated with Osteopoikilosis and Late-Onset Generalized Morphea: A New Buschke-Ollendorf Syndrome Variant.
Korman B; Wei J; Laumann A; Ferguson P; Varga J
Case Rep Dermatol Med; 2016; 2016():2483041. PubMed ID: 27382493
[TBL] [Abstract][Full Text] [Related]
26. Melorheostosis in a family with autosomal dominant osteopoikilosis: report of a third family.
Debeer P; Pykels E; Lammens J; Devriendt K; Fryns JP
Am J Med Genet A; 2003 Jun; 119A(2):188-93. PubMed ID: 12749062
[TBL] [Abstract][Full Text] [Related]
27. RNA recognition motif of LEMD3 as a key player in the pathogenesis of Buschke-Ollendorff syndrome.
Takashima S; Fujita Y; Suzuki S; Saito N; Shinkuma S; Nomura T; Shimizu H
J Dermatol Sci; 2016 Mar; 81(3):205-8. PubMed ID: 26711937
[No Abstract] [Full Text] [Related]
28. Buschke-Ollendorff syndrome due to a novel LEMD3 mutation - an unusual case of alopecia.
Darr-Foit S; Schliemann S; Schulz S; Elsner P
J Dtsch Dermatol Ges; 2018 Mar; 16(3):348-349. PubMed ID: 29465813
[No Abstract] [Full Text] [Related]
29. Buschke-Ollendorff syndrome with LEMD3 germline stopgain mutation p.R678* presenting as multiple subcutaneous nodules with mucin deposition.
Xu Z; Yang C; Xue R
J Cutan Pathol; 2021 Jan; 48(1):77-80. PubMed ID: 32519343
[TBL] [Abstract][Full Text] [Related]
30. LEMD3: the gene responsible for bone density disorders (osteopoikilosis).
Ben-Asher E; Zelzer E; Lancet D
Isr Med Assoc J; 2005 Apr; 7(4):273-4. PubMed ID: 15847215
[No Abstract] [Full Text] [Related]
31. A novel LEMD3 pathogenic variant in a son and mother with osteopoikilosis.
Elmaoğulları S; Yıldız AE; Demir S; Gürkan H; Uçaktürk SA
Turk J Pediatr; 2019; 61(4):594-598. PubMed ID: 31990479
[TBL] [Abstract][Full Text] [Related]
32. [Buschke-Ollendorff syndrome: inactivating mutation of the LEMD3 gene].
Dereure O
Ann Dermatol Venereol; 2005; 132(6-7 Pt 1):593. PubMed ID: 16142115
[No Abstract] [Full Text] [Related]
33. Novel 4-bp Intronic Deletion (c.1560+5_1560+8del) [corrected] in LEMD3 in a Korean Patient With Osteopoikilosis.
Yoo IY; Song JS; Ki CS; Kim JW; Cha HS; Min YK
Ann Lab Med; 2017 Nov; 37(6):540-543. PubMed ID: 28840995
[TBL] [Abstract][Full Text] [Related]
34. Melorheostosis may originate as a type 2 segmental manifestation of osteopoikilosis.
Happle R
Am J Med Genet A; 2004 Mar; 125A(3):221-3. PubMed ID: 14994228
[TBL] [Abstract][Full Text] [Related]
35. Modeling-based bone formation transforms trabeculae to cortical bone in the sclerotic areas in Buschke-Ollendorff syndrome. A case study of two females with LEMD3 variants.
Frost M; Rahbek ET; Ejersted C; Høilund-Carlsen PF; Bygum A; Thomsen JS; Andreasen CM; Andersen TL; Frederiksen AL
Bone; 2020 Jun; 135():115313. PubMed ID: 32151766
[TBL] [Abstract][Full Text] [Related]
36. Depressed indurated plaque with elastorrhexis as a distinctive lesion in Buschke-Ollendorff syndrome.
Velasco Huici R; Martín JM; Vázquez B; Silva E; Estébanez A; Cuesta A; Ramón D; Monteagudo C
Pediatr Dermatol; 2020 Mar; 37(2):385-387. PubMed ID: 31943321
[TBL] [Abstract][Full Text] [Related]
37. A novel heterozygous splice-site mutation of LEM domain-containing 3 in a Japanese kindred with Buschke-Ollendorff syndrome.
Kobayashi H; Kasahara M; Hino M; Takahara S; Ikeda K; Son C; Iwakura T; Matsuoka N; Yoshimoto A; Ohgo N; Kasai R; Ishihara T; Ogawa Y
J Endocrinol Invest; 2007 Mar; 30(3):263-5. PubMed ID: 17505164
[No Abstract] [Full Text] [Related]
38. [A twelve-year-old teenager with bone pain and white papules].
Champion V; Gérard M; Reinert P; Soria I
Arch Pediatr; 2005 Jul; 12(7):1124-8. PubMed ID: 15964529
[TBL] [Abstract][Full Text] [Related]
39. Buschke-Ollendorff syndrome.
Hassikou H; Tabache F; Safi S; Baaj M; Hadri L
Joint Bone Spine; 2008 Mar; 75(2):212-4. PubMed ID: 18313966
[TBL] [Abstract][Full Text] [Related]
40. Osteopoikilosis With Germline LEMD3 Mutation Mimicking Bone Metastases in a Girl With a Concurrent Secreting Mixed Germ Cell Tumor.
Correa Llano MG; Mora J; Torner F; Inarejos E; Cruz O
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e185-e187. PubMed ID: 30951020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]